These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4025384)

  • 1. Comparative toxicities of third-generation cephalosporins.
    Meyers BR
    Am J Med; 1985 Aug; 79(2A):96-103. PubMed ID: 4025384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of parenteral third-generation cephalosporins.
    Fekety FR
    Am J Med; 1990 Apr; 88(4A):38S-44S. PubMed ID: 2183609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
    Nichols RL; Wikler MA; McDevitt JT; Lentnek AL; Hosutt JA
    Antimicrob Agents Chemother; 1987 Feb; 31(2):281-5. PubMed ID: 3471181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of the third generation cephalosporins.
    Balant L; Dayer P; Auckenthaler R
    Clin Pharmacokinet; 1985; 10(2):101-43. PubMed ID: 3888488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
    Clark J; Hochman R; Rolla AR; Thomas S; Miller DG; Kaldany A; D'Elia JA
    Clin Exp Dial Apheresis; 1983; 7(3):177-90. PubMed ID: 6671350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activity of ceftazidime (GR 20263) and other beta-lactamase stable cephalosporins against pseudomonas. Effect of inoculum size and divalent cation supplementation.
    Chow AW; Bartlett KH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():345-8. PubMed ID: 19803012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third generation cephalosporins: safety profiles after 10 years of clinical use.
    Neu HC
    J Clin Pharmacol; 1990 May; 30(5):396-403. PubMed ID: 2189900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cephalosporins of the third generation in therapy of children with severe infections].
    Samsygina GA
    Antibiot Khimioter; 2000; 45(12):32-3. PubMed ID: 11212493
    [No Abstract]   [Full Text] [Related]  

  • 10. The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis.
    Park GH; Kim S; Kim MS; Yu YM; Kim GH; Lee JS; Lee E
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31623191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
    Shimada K; Matsuda T; Inamatsu T; Urayama K
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():325-30. PubMed ID: 6389475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cephalosporin induced coagulopathies.
    Seeler RA; Reitan J
    IMJ Ill Med J; 1984 Nov; 166(5):351-3. PubMed ID: 6150914
    [No Abstract]   [Full Text] [Related]  

  • 13. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
    Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of antibiotic-associated hypoprothrombinemia.
    Schentag JJ; Welage LS; Grasela TH; Adelman MH
    Pharmacotherapy; 1987; 7(3):80-6. PubMed ID: 3306622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
    Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():99-104. PubMed ID: 6296035
    [No Abstract]   [Full Text] [Related]  

  • 16. Third generation cephalosporins.
    Donowitz GR
    Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
    Norrby SR
    Am J Med; 1985 Aug; 79(2A):56-61. PubMed ID: 3895919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions to a cephalosporins in hospitalized patients with a history of penicillin allergy.
    Fonacier L; Hirschberg R; Gerson S
    Allergy Asthma Proc; 2005; 26(2):135-41. PubMed ID: 15971473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.